about
Splenectomy in children with chronic ITP: long-term efficacy and relation between its outcome and responses to previous treatments.Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations.Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia.Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families.Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins.Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS.Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency.Foreign children with cancer in Italy.Late pulmonary sequelae after childhood bone marrow transplantationDevelopment of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemiaImmunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.Streptococcus pneumoniae pharyngeal colonization in school-age children and adolescents with cancerComparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.Immunotherapy against EBV-lymphoma in recipients of HSCT.Experts' considerations on HLA-haploidentical stem cell transplantation.Possible alternatives to antimicrobial therapies.Long Term Outcomes of Cord Blood Transplantation From an HLA-Identical Sibling for Patients with Bone Marrow Failure Disorders: a Report From Eurocord, Cord Blood Committee (CBC-CTIWP) and Severe Aplastic Anemia Working Party (SAAWP) of the EuropeanEfficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial.Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.Gastrointestinal tract carcinoma in pediatric and adolescent age: The Italian TREP project experience.Adolescent and adult uterine volume and uterine artery Doppler blood flow among subjects treated with bone marrow transplantation or chemotherapy in pediatric age: a case-control study.BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.Parental origin of the deletion del(20q) in Shwachman-Diamond patients and loss of the paternally derived allele of the imprinted L3MBTL1 gene.MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatmentHemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010.Toxoplasmosis disease in paediatric hematopoietic stem cell transplantation: do not forget it still exists.Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol.Busulfan.Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study.Persistent rhinovirus infection in pediatric hematopoietic stem cell transplant recipients with impaired cellular immunity.Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.The prognostic value of biological markers in paediatric Hodgkin lymphoma.Evidence for CD19B-CD8T cell interactions in blood and tissues from patients with GvHD.Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.Biological individuality and the new frontiers of immunological tolerance in hematopoietic stem cell transplantation.
P50
Q33372385-129DABC1-FD90-4CD4-9D74-6AA9C0167BE1Q33376077-F7F8A95C-2399-4CB4-8FB2-2D6149FF68B1Q33386154-D55C2788-2706-4AC4-89F7-77F6E617F0FFQ33391827-495B2159-75E0-4F0B-B3E2-01EF714E50EAQ33394807-FF94B11A-4BA9-4972-BAE4-424C6FC620A8Q33490167-EC76461C-07B2-4262-8276-D5DAB7C6D068Q33688517-CE527E50-34FD-4C1E-815C-9486622D753CQ33702157-B4F8984E-8A6F-426D-A58B-6CCEFFF39B45Q34458505-5ADF22AE-E8F2-4836-9420-CBB2068D2165Q35293935-24F256A1-7ECA-42CE-94C2-727C16D3DD0CQ35532955-EDD773E1-CF48-406A-9FE8-01A1D8E90C92Q36407156-C3420DD6-BA6C-43A3-855A-833A457E5450Q37127201-BBEFAA4A-BC2F-4D56-AE0C-1F18E4BAAAD9Q37309233-64C681AD-CDD3-44C1-9D17-CAB80B79318AQ37676271-96F06DEA-0C54-480F-8233-B1A252C99DC4Q37810283-E014EAA9-E7E0-4F3B-BB10-CA43D58C20A5Q38198728-02ECF6F2-62AA-4588-93C0-49273B56B78DQ38202766-7FC4A0FC-EDF7-4DE4-86FE-B27CDC5B7E97Q38629971-1C9099BF-4B3F-4712-846C-E602066C6A48Q38658016-A721727A-CE4E-42E0-A103-A576B08592C2Q38722106-A217DBD8-6973-433A-BE8E-3D9BDA27E012Q38754359-B4954E70-6D02-4939-B6DA-281DCF807D62Q39077691-28698056-1F8F-42C1-AB63-8F77F4C4DE4AQ39122060-EFD9762F-1A2C-47B9-9098-D3DD904B5EA5Q39461796-300A0168-8FD8-4F44-B8F6-B442F01DF23DQ39570483-0333F135-CE63-4795-8BB6-B4DFF3F5D08AQ40122851-871C9BD5-3524-4C26-8142-E266ED02847CQ40163653-17CE167C-1F44-4322-8D68-EB6B96D51CE2Q40316983-3140A22A-86CE-4679-AFE1-FFB3D09133D3Q40558164-97FEE418-9834-4C49-95B9-9D10A941B760Q40902576-961A1F5A-55EC-455E-AE10-E11AB8D6B665Q40919992-3D4A37DF-4758-48E9-B9D5-4FBC28600FCBQ40955845-9A0429BC-8ABA-4887-AC51-CAD8065B751DQ41068390-9FB0EE42-17B6-499B-9CAE-ABED92D8537CQ41078618-6158E2D3-57A5-4F24-99E6-39A4D5A5D588Q41938799-0B6B6097-EAEB-4DA6-A13B-57308AA1F720Q42212281-8ED4CD9A-F43B-41A7-90B3-C1D4C3B5DBD3Q42273138-5C715CAD-B2D5-42FA-AD94-A2AFE67F777EQ42322251-7BC83B8D-24D9-4F3F-A3D2-FF698BB4465EQ42434773-ABEC3ADE-4E76-4211-ACE5-E06DA5DC4BC1
P50
description
researcher
@en
name
M Zecca
@ast
M Zecca
@en
M Zecca
@nl
type
label
M Zecca
@ast
M Zecca
@en
M Zecca
@nl
prefLabel
M Zecca
@ast
M Zecca
@en
M Zecca
@nl
P106
P31
P496
0000-0002-8818-1744